UNIVERSITY OF WASHINGTON

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1861-01-01

Employees: 10K

Market Cap: -

Website: https://www.cs.washington.edu

Clinical Trials

The Partners Scale-Up Project

Phase 4

Completed

Conditions: HIV-1-infection

Interventions: Other: Integrated PrEP as a bridge to ART HIV-1 prevention strategy
Drug: PrEP
Drug: ART

First Posted Date: 2017-02-14

Last Posted Date: 2021-10-19

Lead Sponsor: University of Washington

Target Recruit Count: 4898

Registration Number: NCT03052010

Locations: 🇰🇪
KEMRI, Kisumu, Kenya
🇰🇪
Partners in Health Research and Development, Thika, Kenya

American Indian and Alaska Native Men Who Have Sex With Men HIV & Substance Abuse Research

Not Applicable

Completed

Conditions: HIV
Substance Use

Interventions: Behavioral: Vr2L 2Spirit

First Posted Date: 2017-02-10

Last Posted Date: 2018-04-30

Lead Sponsor: University of Washington

Target Recruit Count: 79

Registration Number: NCT03049904

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, Pembrolizumab, Nivolumab and Atezolizumab in Treating Patients With Advanced Melanoma, Lung, or Kidney Cancer

Phase 2

Terminated

Conditions: Metastatic Kidney Carcinoma
Recurrent Lung Non-Small Cell Carcinoma
Stage IV Cutaneous Melanoma AJCC v6 and v7
Stage IV Renal Cell Cancer AJCC v7
Stage IV Lung Non-Small Cell Cancer AJCC v7

Interventions: Drug: Atezolizumab
Radiation: Hypofractionated Radiation Therapy
Other: Laboratory Biomarker Analysis
Drug: Nelfinavir Mesylate
Biological: Nivolumab
Biological: Pembrolizumab

First Posted Date: 2017-02-10

Last Posted Date: 2022-06-22

Lead Sponsor: University of Washington

Target Recruit Count: 21

Registration Number: NCT03050060

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Financial Incentives to Increase Pediatric HIV Testing

Not Applicable

Completed

Conditions: HIV

Interventions: Behavioral: Financial incentive

First Posted Date: 2017-02-10

Last Posted Date: 2021-06-25

Lead Sponsor: University of Washington

Target Recruit Count: 452

Registration Number: NCT03049917

Locations: 🇰🇪
Kisumu County Hospital, Kisumu, Kenya

PainTracker Self-Manager: a Web-based Platform to Promote and Track Chronic Pain Self-management

Not Applicable

Completed

Conditions: Chronic Pain

Interventions: Behavioral: PainTracker Self-Manager

First Posted Date: 2017-02-07

Last Posted Date: 2019-11-12

Lead Sponsor: University of Washington

Target Recruit Count: 99

Registration Number: NCT03045081

Locations: 🇺🇸
University of Washington Center for Pain Relief, Seattle, Washington, United States

Union Rate of Transverse Tibia Fracture

Not Applicable

Terminated

Conditions: Closed Transverse Fracture of Shaft of Tibia

Interventions: Device: Standard Backslapping
Device: Conventional Compression
Device: Dynamic Locking with Backslapping

First Posted Date: 2017-02-03

Last Posted Date: 2024-05-03

Lead Sponsor: University of Washington

Target Recruit Count: 9

Registration Number: NCT03042533

Locations: 🇺🇸
Harborview Medical Center, Seattle, Washington, United States

Calcium Sulfate Spacer in Open Tibia Fractures

Phase 4

Terminated

Conditions: Open tíbia Fracture With Sub-segmental Bone Loss

Interventions: Other: No treatment
Drug: PMMA
Drug: Calcium Sulfate

First Posted Date: 2017-02-03

Last Posted Date: 2023-02-10

Lead Sponsor: University of Washington

Target Recruit Count: 1

Registration Number: NCT03042546

Locations: 🇺🇸
Harborview Medical Center, Seattle, Washington, United States

Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ)

Phase 3

Conditions: Medication-related Osteonecrosis of the Jaw
Bisphosphonate-related Osteonecrosis of the Jaw
Avascular Necrosis

Interventions: Drug: Placebo
Drug: Pentoxifylline
Drug: Tocopherol

First Posted Date: 2017-02-02

Last Posted Date: 2024-05-31

Lead Sponsor: University of Washington

Target Recruit Count: 100

Registration Number: NCT03040778

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
University of Washington, Seattle, Washington, United States
🇺🇸
New York Center for Orthognathic and Maxillofacial Surgery, Lake Success, New York, United States

and more 1 locations

Effect of Randomization to Neuromuscular Blockade on Physical Functional Impairment and Recovery in ARDS

Conditions: Neuromyopathies
Acute Respiratory Distress Syndrome

First Posted Date: 2017-02-01

Last Posted Date: 2017-02-01

Lead Sponsor: University of Washington

Target Recruit Count: 290

Registration Number: NCT03038906

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Personalized Health Assessment Related to Medications (Project PHARM)

Not Applicable

Completed

Conditions: Substance Abuse
Feedback, Psychological
Clinical Trial

Interventions: Behavioral: Web-based PFI
Behavioral: Assessment Only

First Posted Date: 2017-01-31

Last Posted Date: 2023-08-01

Lead Sponsor: University of Washington

Target Recruit Count: 843

Registration Number: NCT03037476

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy